speb/financial-data huggingface dataset:
CXE balance_sheet (quarterly, 2025-05-31) — Net Tangible Assets: 124749393.00
CXE balance_sheet (quarterly, 2025-05-31) — Ordinary Shares Number: 31525773.00
CXE balance_sheet (quarterly, 2025-05-31) — Other Payable: 12426255.00
CXE balance_sheet (quarterly, 2025-05-31) — Payables: 13860688.00
CXE balance_sheet (quarterly, 2025-05-31) — Preferred Securities Outside Stock Equity: 69200000.00
CXE balance_sheet (quarterly, 2025-05-31) — Receivables: 3720869.00
CXE balance_sheet (quarterly, 2025-05-31) — Retained Earnings: -29105161.00
CXE balance_sheet (quarterly, 2025-05-31) — Share Issued: 31525773.00
CXE balance_sheet (quarterly, 2025-05-31) — Stockholders Equity: 124749393.00
CXE balance_sheet (quarterly, 2025-05-31) — Tangible Book Value: 124749393.00
CXE balance_sheet (quarterly, 2025-05-31) — Total Assets: 207899410.00
CXE balance_sheet (quarterly, 2025-05-31) — Total Equity Gross Minority Interest: 124749393.00
CXE balance_sheet (quarterly, 2025-05-31) — Total Liabilities Net Minority Interest: 83150017.00
CXE income_statement (annual, 2025-11-30) — +Operating Expense: -79248.00
CXE income_statement (annual, 2025-11-30) — +Total Revenue: -3560.00
CXE balance_sheet (annual, 2025-11-30) — Accounts Payable: 1848161.00
CXE balance_sheet (quarterly, 2025-11-30) — Accounts Payable: 1848161.00
CXE cash_flow (annual, 2025-11-30) — Beginning Cash Position: 64451.00
CXE balance_sheet (annual, 2025-11-30) — Capital Stock: 153854554.00
CXE balance_sheet (quarterly, 2025-11-30) — Capital Stock: 153854554.00
CXE cash_flow (annual, 2025-11-30) — Cash Dividends Paid: -6461719.00
CXE cash_flow (annual, 2025-11-30) — Change In Accrued Expense: -9567.00
CXE cash_flow (annual, 2025-11-30) — Change In Other Current Assets: -14.00
CXE cash_flow (annual, 2025-11-30) — Change In Other Current Liabilities: 0.00
CXE cash_flow (annual, 2025-11-30) — Change In Payable: -32276.00
CXE cash_flow (annual, 2025-11-30) — Change In Receivables: -11367.00
CXE cash_flow (annual, 2025-11-30) — Change In Working Capital: -53224.00
CXE cash_flow (annual, 2025-11-30) — Changes In Cash: -64451.00
CXE balance_sheet (annual, 2025-11-30) — Common Stock: 153854554.00
CXE balance_sheet (quarterly, 2025-11-30) — Common Stock: 153854554.00
CXE cash_flow (annual, 2025-11-30) — Common Stock Dividend Paid: -6461719.00
CXE balance_sheet (annual, 2025-11-30) — Common Stock Equity: 130583755.00
CXE balance_sheet (quarterly, 2025-11-30) — Common Stock Equity: 130583755.00
CXE income_statement (annual, 2025-11-30) — Diluted NI Availto Com Stockholders: 75688.00
CXE cash_flow (annual, 2025-11-30) — End Cash Position: 0.00
CXE balance_sheet (annual, 2025-11-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 210245569.00
CXE balance_sheet (quarterly, 2025-11-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 210245569.00
CXE cash_flow (annual, 2025-11-30) — Financing Cash Flow: -6471719.00
CXE cash_flow (annual, 2025-11-30) — Free Cash Flow: 6407268.00
CXE cash_flow (annual, 2025-11-30) — Gain Loss On Investment Securities: 6104649.00
CXE income_statement (annual, 2025-11-30) — Gain On Sale Of Security: -2246061.00
CXE income_statement (annual, 2025-11-30) — General And Administrative Expense: 317115.00
CXE income_statement (annual, 2025-11-30) — Interest Expense: 3143072.00
CXE income_statement (annual, 2025-11-30) — Interest Income: 10161421.00
CXE balance_sheet (annual, 2025-11-30) — Investmentin Financial Assets: 210245569.00
CXE balance_sheet (quarterly, 2025-11-30) — Investmentin Financial Assets: 210245569.00
CXE balance_sheet (annual, 2025-11-30) — Investments And Advances: 210245569.00
CXE balance_sheet (quarterly, 2025-11-30) — Investments And Advances: 210245569.00
CXE cash_flow (annual, 2025-11-30) — Issuance Of Debt: 1500000.00
CXE cash_flow (annual, 2025-11-30) — Long Term Debt Issuance: 1500000.00
CXE cash_flow (annual, 2025-11-30) — Long Term Debt Payments: -1510000.00
CXE income_statement (annual, 2025-11-30) — Net Income: 75688.00
CXE income_statement (annual, 2025-11-30) — Net Income Common Stockholders: 75688.00
CXE income_statement (annual, 2025-11-30) — Net Income Continuous Operations: 75688.00
CXE income_statement (annual, 2025-11-30) — Net Income From Continuing And Discontinued Operation: 75688.00
CXE income_statement (annual, 2025-11-30) — Net Income From Continuing Operation Net Minority Interest: 75688.00
CXE cash_flow (annual, 2025-11-30) — Net Income From Continuing Operations: 75688.00
CXE income_statement (annual, 2025-11-30) — Net Income Including Noncontrolling Interests: 75688.00
CXE income_statement (annual, 2025-11-30) — Net Interest Income: 7018349.00
CXE cash_flow (annual, 2025-11-30) — Net Issuance Payments Of Debt: -10000.00
CXE cash_flow (annual, 2025-11-30) — Net Long Term Debt Issuance: -10000.00
CXE cash_flow (annual, 2025-11-30) — Net Other Financing Charges: 0.00
CXE balance_sheet (annual, 2025-11-30) — Net Tangible Assets: 130583755.00
CXE balance_sheet (quarterly, 2025-11-30) — Net Tangible Assets: 130583755.00
CXE income_statement (annual, 2025-11-30) — Normalized Income: 75688.00
CXE cash_flow (annual, 2025-11-30) — Operating Cash Flow: 6407268.00
CXE income_statement (annual, 2025-11-30) — Operating Revenue: -3560.00
CXE balance_sheet (annual, 2025-11-30) — Ordinary Shares Number: 31525773.00
CXE balance_sheet (quarterly, 2025-11-30) — Ordinary Shares Number: 31525773.00
CXE cash_flow (annual, 2025-11-30) — Other Non Cash Items: 280155.00
CXE income_statement (annual, 2025-11-30) — Other Operating Expenses: -396363.00
CXE balance_sheet (annual, 2025-11-30) — Other Payable: 12371615.00
CXE balance_sheet (quarterly, 2025-11-30) — Other Payable: 12371615.00
CXE balance_sheet (annual, 2025-11-30) — Payables: 14219776.00
CXE balance_sheet (quarterly, 2025-11-30) — Payables: 14219776.00
CXE balance_sheet (annual, 2025-11-30) — Preferred Securities Outside Stock Equity: 69200000.00
CXE balance_sheet (quarterly, 2025-11-30) — Preferred Securities Outside Stock Equity: 69200000.00
CXE income_statement (annual, 2025-11-30) — Pretax Income: 75688.00
CXE balance_sheet (annual, 2025-11-30) — Receivables: 3867983.00
CXE balance_sheet (quarterly, 2025-11-30) — Receivables: 3867983.00
CXE cash_flow (annual, 2025-11-30) — Repayment Of Debt: -1510000.00
CXE balance_sheet (annual, 2025-11-30) — Retained Earnings: -23270799.00
CXE balance_sheet (quarterly, 2025-11-30) — Retained Earnings: -23270799.00
CXE income_statement (annual, 2025-11-30) — Selling General And Administration: 317115.00
CXE balance_sheet (annual, 2025-11-30) — Share Issued: 31525773.00
CXE balance_sheet (quarterly, 2025-11-30) — Share Issued: 31525773.00
CXE balance_sheet (annual, 2025-11-30) — Stockholders Equity: 130583755.00
CXE balance_sheet (quarterly, 2025-11-30) — Stockholders Equity: 130583755.00
CXE balance_sheet (annual, 2025-11-30) — Tangible Book Value: 130583755.00
CXE balance_sheet (quarterly, 2025-11-30) — Tangible Book Value: 130583755.00
CXE income_statement (annual, 2025-11-30) — Tax Effect Of Unusual Items: 0.00
CXE income_statement (annual, 2025-11-30) — Tax Rate For Calcs: 0.21
CXE balance_sheet (annual, 2025-11-30) — Total Assets: 214116162.00
CXE balance_sheet (quarterly, 2025-11-30) — Total Assets: 214116162.00
CXE balance_sheet (annual, 2025-11-30) — Total Equity Gross Minority Interest: 130583755.00
CXE balance_sheet (quarterly, 2025-11-30) — Total Equity Gross Minority Interest: 130583755.00
CXE balance_sheet (annual, 2025-11-30) — Total Liabilities Net Minority Interest: 83532407.00
CXE balance_sheet (quarterly, 2025-11-30) — Total Liabilities Net Minority Interest: 83532407.00
CXH income_statement (annual, 2021-11-30) — Basic Average Shares: 9163306.00
CXH income_statement (annual, 2021-11-30) — Basic EPS: 0.54
CXH balance_sheet (annual, 2021-11-30) — Cash And Cash Equivalents: 3140153.00
CXH balance_sheet (annual, 2021-11-30) — Cash Cash Equivalents And Federal Funds Sold: 3140153.00
CXH balance_sheet (annual, 2021-11-30) — Cash Financial: 3140153.00
CXH income_statement (annual, 2021-11-30) — Diluted Average Shares: 9163306.00
CXH income_statement (annual, 2021-11-30) — Diluted EPS: 0.54
CXH cash_flow (annual, 2021-11-30) — Issuance Of Capital Stock: 48800000.00
CXH cash_flow (annual, 2021-11-30) — Long Term Debt Payments: -1260000.00
CXH cash_flow (annual, 2021-11-30) — Net Preferred Stock Issuance: 50000.00
CXH cash_flow (annual, 2021-11-30) — Preferred Stock Issuance: 48800000.00
CXH cash_flow (annual, 2021-11-30) — Preferred Stock Payments: -48750000.00
CXH cash_flow (annual, 2021-11-30) — Repayment Of Debt: -1260000.00
CXH cash_flow (annual, 2021-11-30) — Repurchase Of Capital Stock: -48750000.00
CXH income_statement (annual, 2022-11-30) — +Operating Expense: 172093.00
CXH income_statement (annual, 2022-11-30) — +Total Revenue: -18167043.00
CXH balance_sheet (annual, 2022-11-30) — Accounts Payable: 798008.00
CXH income_statement (annual, 2022-11-30) — Basic Average Shares: 9169568.00
CXH income_statement (annual, 2022-11-30) — Basic EPS: -2.00
CXH cash_flow (annual, 2022-11-30) — Beginning Cash Position: 3140153.00
CXH balance_sheet (annual, 2022-11-30) — Capital Stock: 85368200.00
CXH cash_flow (annual, 2022-11-30) — Cash Dividends Paid: -3753023.00
CXH cash_flow (annual, 2022-11-30) — Change In Accrued Expense: -27051.00
CXH cash_flow (annual, 2022-11-30) — Change In Other Current Assets: 3.00
CXH cash_flow (annual, 2022-11-30) — Change In Other Current Liabilities: 0.00
CXH cash_flow (annual, 2022-11-30) — Change In Payable: -24526.00
CXH cash_flow (annual, 2022-11-30) — Change In Receivables: 226702.00
CXH cash_flow (annual, 2022-11-30) — Change In Working Capital: 175128.00
CXH cash_flow (annual, 2022-11-30) — Changes In Cash: -3140153.00
CXH balance_sheet (annual, 2022-11-30) — Common Stock: 85368200.00
CXH cash_flow (annual, 2022-11-30) — Common Stock Dividend Paid: -3753023.00
CXH balance_sheet (annual, 2022-11-30) — Common Stock Equity: 76685028.00
CXH income_statement (annual, 2022-11-30) — Diluted Average Shares: 9169568.00
CXH income_statement (annual, 2022-11-30) — Diluted EPS: -2.00
CXH income_statement (annual, 2022-11-30) — Diluted NI Availto Com Stockholders: -18339136.00
CXH cash_flow (annual, 2022-11-30) — End Cash Position: 0.00
CXH balance_sheet (annual, 2022-11-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 127298247.00
CXH cash_flow (annual, 2022-11-30) — Financing Cash Flow: -2837888.00
CXH cash_flow (annual, 2022-11-30) — Free Cash Flow: -302265.00
CXH cash_flow (annual, 2022-11-30) — Gain Loss On Investment Securities: 17216795.00
CXH income_statement (annual, 2022-11-30) — Gain On Sale Of Security: -2757447.00
CXH income_statement (annual, 2022-11-30) — General And Administrative Expense: 261426.00
CXH income_statement (annual, 2022-11-30) — Interest Expense: 1023676.00
CXH income_statement (annual, 2022-11-30) — Interest Income: 4945770.00
CXH balance_sheet (annual, 2022-11-30) — Investmentin Financial Assets: 127298247.00
CXH balance_sheet (annual, 2022-11-30) — Investments And Advances: 127298247.00
CXH cash_flow (annual, 2022-11-30) — Long Term Debt Payments: -910000.00
CXH income_statement (annual, 2022-11-30) — Net Income: -18339136.00
CXH income_statement (annual, 2022-11-30) — Net Income Common Stockholders: -18339136.00
CXH income_statement (annual, 2022-11-30) — Net Income Continuous Operations: -18339136.00
CXH income_statement (annual, 2022-11-30) — Net Income From Continuing And Discontinued Operation: -18339136.00
CXH income_statement (annual, 2022-11-30) — Net Income From Continuing Operation Net Minority Interest: -18339136.00
CXH cash_flow (annual, 2022-11-30) — Net Income From Continuing Operations: -18339136.00
CXH income_statement (annual, 2022-11-30) — Net Income Including Noncontrolling Interests: -18339136.00
CXH income_statement (annual, 2022-11-30) — Net Interest Income: 3922094.00
CXH cash_flow (annual, 2022-11-30) — Net Issuance Payments Of Debt: -910000.00
CXH cash_flow (annual, 2022-11-30) — Net Long Term Debt Issuance: -910000.00
CXH cash_flow (annual, 2022-11-30) — Net Other Financing Charges: 1825135.00
CXH balance_sheet (annual, 2022-11-30) — Net Tangible Assets: 76685028.00
CXH income_statement (annual, 2022-11-30) — Normalized Income: -18339136.00
CXH cash_flow (annual, 2022-11-30) — Operating Cash Flow: -302265.00
CXH income_statement (annual, 2022-11-30) — Operating Revenue: -18167043.00
CXH balance_sheet (annual, 2022-11-30) — Ordinary Shares Number: 9110245.00
CXH cash_flow (annual, 2022-11-30) — Other Non Cash Items: 644948.00
CXH income_statement (annual, 2022-11-30) — Other Operating Expenses: -89333.00
CXH balance_sheet (annual, 2022-11-30) — Other Payable: 2761156.00
CXH balance_sheet (annual, 2022-11-30) — Payables: 3559164.00
CXH balance_sheet (annual, 2022-11-30) — Preferred Securities Outside Stock Equity: 48735868.00
CXH income_statement (annual, 2022-11-30) — Pretax Income: -18339136.00
CXH balance_sheet (annual, 2022-11-30) — Receivables: 1775684.00
CXH cash_flow (annual, 2022-11-30) — Repayment Of Debt: -910000.00
CXH balance_sheet (annual, 2022-11-30) — Retained Earnings: -8683172.00
CXH income_statement (annual, 2022-11-30) — Selling General And Administration: 261426.00
CXH balance_sheet (annual, 2022-11-30) — Share Issued: 9110245.00
CXH balance_sheet (annual, 2022-11-30) — Stockholders Equity: 76685028.00
CXH balance_sheet (annual, 2022-11-30) — Tangible Book Value: 76685028.00
CXH income_statement (annual, 2022-11-30) — Tax Effect Of Unusual Items: 0.00
CXH income_statement (annual, 2022-11-30) — Tax Rate For Calcs: 0.00
CXH balance_sheet (annual, 2022-11-30) — Total Assets: 129075946.00
CXH balance_sheet (annual, 2022-11-30) — Total Equity Gross Minority Interest: 76685028.00
CXH balance_sheet (annual, 2022-11-30) — Total Liabilities Net Minority Interest: 52390918.00
CXH income_statement (annual, 2023-11-30) — +Operating Expense: 289185.00
CXH income_statement (annual, 2023-11-30) — +Total Revenue: 1862115.00
CXH balance_sheet (annual, 2023-11-30) — Accounts Payable: 1793694.00
CXH income_statement (annual, 2023-11-30) — Basic Average Shares: 6838826.00
CXH income_statement (annual, 2023-11-30) — Basic EPS: 0.23
CXH cash_flow (annual, 2023-11-30) — Beginning Cash Position: 0.00
CXH balance_sheet (annual, 2023-11-30) — Capital Stock: 78374419.00
CXH cash_flow (annual, 2023-11-30) — Cash Dividends Paid: -2510105.00
CXH cash_flow (annual, 2023-11-30) — Change In Accrued Expense: 4842.00
CXH cash_flow (annual, 2023-11-30) — Change In Other Current Assets: -1.00
CXH cash_flow (annual, 2023-11-30) — Change In Other Current Liabilities: 0.00
CXH cash_flow (annual, 2023-11-30) — Change In Payable: 135777.00
CXH cash_flow (annual, 2023-11-30) — Change In Receivables: 23436.00
CXH cash_flow (annual, 2023-11-30) — Change In Working Capital: 164054.00
CXH cash_flow (annual, 2023-11-30) — Changes In Cash: 0.00
CXH balance_sheet (annual, 2023-11-30) — Common Stock: 78374419.00
CXH cash_flow (annual, 2023-11-30) — Common Stock Dividend Paid: -2510105.00
CXH balance_sheet (annual, 2023-11-30) — Common Stock Equity: 68795142.00
CXH cash_flow (annual, 2023-11-30) — Common Stock Issuance: 86861.00
CXH cash_flow (annual, 2023-11-30) — Common Stock Payments: -6954765.00
CXH income_statement (annual, 2023-11-30) — Diluted Average Shares: 6838826.00
CXH income_statement (annual, 2023-11-30) — Diluted EPS: 0.23
CXH income_statement (annual, 2023-11-30) — Diluted NI Availto Com Stockholders: 1572930.00
CXH cash_flow (annual, 2023-11-30) — End Cash Position: 0.00
CXH balance_sheet (annual, 2023-11-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 112784931.00
CXH cash_flow (annual, 2023-11-30) — Financing Cash Flow: -11841908.00
CXH cash_flow (annual, 2023-11-30) — Free Cash Flow: 11841908.00
CXH cash_flow (annual, 2023-11-30) — Gain Loss On Investment Securities: 9807121.00
CXH income_statement (annual, 2023-11-30) — Gain On Sale Of Security: -3767735.00
CXH income_statement (annual, 2023-11-30) — General And Administrative Expense: 406861.00
CXH income_statement (annual, 2023-11-30) — Interest Expense: 2132449.00
CXH income_statement (annual, 2023-11-30) — Interest Income: 5381366.00
CXH balance_sheet (annual, 2023-11-30) — Investmentin Financial Assets: 112784931.00
CXH balance_sheet (annual, 2023-11-30) — Investments And Advances: 112784931.00
CXH cash_flow (annual, 2023-11-30) — Issuance Of Capital Stock: 86861.00
CXH cash_flow (annual, 2023-11-30) — Long Term Debt Payments: -2760000.00
CXH cash_flow (annual, 2023-11-30) — Net Common Stock Issuance: -6867904.00
CXH income_statement (annual, 2023-11-30) — Net Income: 1572930.00
CXH income_statement (annual, 2023-11-30) — Net Income Common Stockholders: 1572930.00
CXH income_statement (annual, 2023-11-30) — Net Income Continuous Operations: 1572930.00
CXH income_statement (annual, 2023-11-30) — Net Income From Continuing And Discontinued Operation: 1572930.00
CXH income_statement (annual, 2023-11-30) — Net Income From Continuing Operation Net Minority Interest: 1572930.00
CXH cash_flow (annual, 2023-11-30) — Net Income From Continuing Operations: 1572930.00
CXH income_statement (annual, 2023-11-30) — Net Income Including Noncontrolling Interests: 1572930.00
CXH income_statement (annual, 2023-11-30) — Net Interest Income: 3248917.00
CXH cash_flow (annual, 2023-11-30) — Net Issuance Payments Of Debt: -2760000.00
CXH cash_flow (annual, 2023-11-30) — Net Long Term Debt Issuance: -2760000.00
CXH cash_flow (annual, 2023-11-30) — Net Other Financing Charges: 5296101.00
CXH cash_flow (annual, 2023-11-30) — Net Preferred Stock Issuance: -5000000.00
CXH balance_sheet (annual, 2023-11-30) — Net Tangible Assets: 68795142.00
CXH income_statement (annual, 2023-11-30) — Normalized Income: 1572930.00
CXH cash_flow (annual, 2023-11-30) — Operating Cash Flow: 11841908.00
CXH income_statement (annual, 2023-11-30) — Operating Revenue: 1862115.00
CXH balance_sheet (annual, 2023-11-30) — Ordinary Shares Number: 8199220.00
CXH cash_flow (annual, 2023-11-30) — Other Non Cash Items: 297803.00
CXH income_statement (annual, 2023-11-30) — Other Operating Expenses: -117676.00
CXH balance_sheet (annual, 2023-11-30) — Other Payable: 500.00
CXH balance_sheet (annual, 2023-11-30) — Payables: 1794194.00
CXH balance_sheet (annual, 2023-11-30) — Preferred Securities Outside Stock Equity: 43774884.00
CXH cash_flow (annual, 2023-11-30) — Preferred Stock Payments: -5000000.00
CXH income_statement (annual, 2023-11-30) — Pretax Income: 1572930.00
CXH balance_sheet (annual, 2023-11-30) — Receivables: 1678229.00
CXH cash_flow (annual, 2023-11-30) — Repayment Of Debt: -2760000.00
CXH cash_flow (annual, 2023-11-30) — Repurchase Of Capital Stock: -11954765.00
CXH balance_sheet (annual, 2023-11-30) — Retained Earnings: -9579277.00
CXH income_statement (annual, 2023-11-30) — Selling General And Administration: 406861.00
CXH balance_sheet (annual, 2023-11-30) — Share Issued: 8199220.00
CXH balance_sheet (annual, 2023-11-30) — Stockholders Equity: 68795142.00
CXH balance_sheet (annual, 2023-11-30) — Tangible Book Value: 68795142.00
CXH income_statement (annual, 2023-11-30) — Tax Effect Of Unusual Items: 0.00
CXH income_statement (annual, 2023-11-30) — Tax Rate For Calcs: 0.21
CXH balance_sheet (annual, 2023-11-30) — Total Assets: 114465176.00
CXH balance_sheet (annual, 2023-11-30) — Total Equity Gross Minority Interest: 68795142.00
CXH balance_sheet (annual, 2023-11-30) — Total Liabilities Net Minority Interest: 45670034.00
CXH income_statement (annual, 2024-11-30) — +Operating Expense: 79490.00
CXH income_statement (annual, 2024-11-30) — +Total Revenue: 1010959.40
CXH balance_sheet (annual, 2024-11-30) — Accounts Payable: 855867.00
CXH balance_sheet (quarterly, 2024-11-30) — Accounts Payable: 855867.00
CXH income_statement (annual, 2024-11-30) — Basic Average Shares: 8242195.00
CXH income_statement (annual, 2024-11-30) — Basic EPS: 0.88
CXH cash_flow (annual, 2024-11-30) — Beginning Cash Position: 0.00
CXH balance_sheet (annual, 2024-11-30) — Capital Stock: 78355439.00
CXH balance_sheet (quarterly, 2024-11-30) — Capital Stock: 78355439.00
CXH balance_sheet (annual, 2024-11-30) — Cash And Cash Equivalents: 31456.00
CXH balance_sheet (quarterly, 2024-11-30) — Cash And Cash Equivalents: 31456.00
CXH balance_sheet (annual, 2024-11-30) — Cash Cash Equivalents And Federal Funds Sold: 31456.00
CXH balance_sheet (quarterly, 2024-11-30) — Cash Cash Equivalents And Federal Funds Sold: 31456.00
CXH cash_flow (annual, 2024-11-30) — Cash Dividends Paid: -2479075.00
CXH balance_sheet (annual, 2024-11-30) — Cash Financial: 31456.00
CXH balance_sheet (quarterly, 2024-11-30) — Cash Financial: 31456.00
CXH cash_flow (annual, 2024-11-30) — Change In Accrued Expense: 14166.00
CXH cash_flow (annual, 2024-11-30) — Change In Other Current Assets: 8.00
CXH cash_flow (annual, 2024-11-30) — Change In Other Current Liabilities: 0.00
CXH cash_flow (annual, 2024-11-30) — Change In Payable: 43973.00
CXH cash_flow (annual, 2024-11-30) — Change In Receivables: -68235.00
CXH cash_flow (annual, 2024-11-30) — Change In Working Capital: -10088.00
CXH cash_flow (annual, 2024-11-30) — Changes In Cash: 31456.00
CXH balance_sheet (annual, 2024-11-30) — Common Stock: 78355439.00
CXH balance_sheet (quarterly, 2024-11-30) — Common Stock: 78355439.00
CXH cash_flow (annual, 2024-11-30) — Common Stock Dividend Paid: -2479075.00
CXH balance_sheet (annual, 2024-11-30) — Common Stock Equity: 73568010.00
CXH balance_sheet (quarterly, 2024-11-30) — Common Stock Equity: 73568010.00
CXH cash_flow (annual, 2024-11-30) — Common Stock Payments: -86861.00
CXH income_statement (annual, 2024-11-30) — Diluted Average Shares: 8242195.00
CXH income_statement (annual, 2024-11-30) — Diluted EPS: 0.88
CXH income_statement (annual, 2024-11-30) — Diluted NI Availto Com Stockholders: 7253132.00
CXH cash_flow (annual, 2024-11-30) — End Cash Position: 31456.00
CXH balance_sheet (annual, 2024-11-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 116723832.00
CXH balance_sheet (quarterly, 2024-11-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 116723832.00
CXH cash_flow (annual, 2024-11-30) — Financing Cash Flow: -2400936.00
CXH cash_flow (annual, 2024-11-30) — Free Cash Flow: 2432392.00
CXH cash_flow (annual, 2024-11-30) — Gain Loss On Investment Securities: -4997350.00
CXH income_statement (annual, 2024-11-30) — Gain On Sale Of Security: -529716.00
CXH income_statement (annual, 2024-11-30) — General And Administrative Expense: 278880.00
CXH income_statement (annual, 2024-11-30) — Interest Expense: 1994126.00
CXH income_statement (annual, 2024-11-30) — Interest Income: 5219570.00
CXH balance_sheet (annual, 2024-11-30) — Investmentin Financial Assets: 116723832.00
CXH balance_sheet (quarterly, 2024-11-30) — Investmentin Financial Assets: 116723832.00
CXH balance_sheet (annual, 2024-11-30) — Investments And Advances: 116723832.00
CXH balance_sheet (quarterly, 2024-11-30) — Investments And Advances: 116723832.00
CXH cash_flow (annual, 2024-11-30) — Issuance Of Debt: 6765000.00
CXH cash_flow (annual, 2024-11-30) — Long Term Debt Issuance: 6765000.00
CXH cash_flow (annual, 2024-11-30) — Net Common Stock Issuance: -86861.00
CXH income_statement (annual, 2024-11-30) — Net Income: 1000000.00
CXH income_statement (annual, 2024-11-30) — Net Income Common Stockholders: 7253132.00
CXH income_statement (annual, 2024-11-30) — Net Income Continuous Operations: 7253132.00
CXH income_statement (annual, 2024-11-30) — Net Income From Continuing And Discontinued Operation: 7253132.00
CXH income_statement (annual, 2024-11-30) — Net Income From Continuing Operation Net Minority Interest: 7253132.00
CXH cash_flow (annual, 2024-11-30) — Net Income From Continuing Operations: 7253132.00
CXH income_statement (annual, 2024-11-30) — Net Income Including Noncontrolling Interests: 7253132.00
CXH income_statement (annual, 2024-11-30) — Net Interest Income: 3225444.00
CXH cash_flow (annual, 2024-11-30) — Net Issuance Payments Of Debt: 6765000.00
CXH cash_flow (annual, 2024-11-30) — Net Long Term Debt Issuance: 6765000.00
CXH cash_flow (annual, 2024-11-30) — Net Other Financing Charges: 0.00
CXH cash_flow (annual, 2024-11-30) — Net Preferred Stock Issuance: -6600000.00
CXH balance_sheet (annual, 2024-11-30) — Net Tangible Assets: 73568010.00
CXH balance_sheet (quarterly, 2024-11-30) — Net Tangible Assets: 73568010.00
CXH income_statement (annual, 2024-11-30) — Normalized Income: 7253132.00
CXH cash_flow (annual, 2024-11-30) — Operating Cash Flow: 2432392.00
CXH income_statement (annual, 2024-11-30) — Operating Revenue: 1010959.40
CXH balance_sheet (annual, 2024-11-30) — Ordinary Shares Number: 8199220.00
CXH balance_sheet (quarterly, 2024-11-30) — Ordinary Shares Number: 8199220.00
CXH cash_flow (annual, 2024-11-30) — Other Non Cash Items: 186698.00
CXH income_statement (annual, 2024-11-30) — Other Operating Expenses: -199390.00
CXH balance_sheet (annual, 2024-11-30) — Other Payable: 6770272.00
CXH balance_sheet (quarterly, 2024-11-30) — Other Payable: 6770272.00
CXH balance_sheet (annual, 2024-11-30) — Payables: 7626139.00
CXH balance_sheet (quarterly, 2024-11-30) — Payables: 7626139.00
CXH balance_sheet (annual, 2024-11-30) — Preferred Securities Outside Stock Equity: 37200000.00
CXH balance_sheet (quarterly, 2024-11-30) — Preferred Securities Outside Stock Equity: 37200000.00
CXH cash_flow (annual, 2024-11-30) — Preferred Stock Payments: -6600000.00
CXH income_statement (annual, 2024-11-30) — Pretax Income: 7253132.00
CXH balance_sheet (annual, 2024-11-30) — Receivables: 1751706.00
CXH balance_sheet (quarterly, 2024-11-30) — Receivables: 1751706.00
CXH cash_flow (annual, 2024-11-30) — Repurchase Of Capital Stock: -6686861.00
CXH balance_sheet (annual, 2024-11-30) — Retained Earnings: -4787429.00
CXH balance_sheet (quarterly, 2024-11-30) — Retained Earnings: -4787429.00
CXH income_statement (annual, 2024-11-30) — Selling General And Administration: 278880.00
CXH balance_sheet (annual, 2024-11-30) — Share Issued: 8199220.00
CXH balance_sheet (quarterly, 2024-11-30) — Share Issued: 8199220.00
CXH balance_sheet (annual, 2024-11-30) — Stockholders Equity: 73568010.00
CXH balance_sheet (quarterly, 2024-11-30) — Stockholders Equity: 73568010.00
CXH balance_sheet (annual, 2024-11-30) — Tangible Book Value: 73568010.00
CXH balance_sheet (quarterly, 2024-11-30) — Tangible Book Value: 73568010.00
CXH income_statement (annual, 2024-11-30) — Tax Effect Of Unusual Items: 0.00
CXH income_statement (annual, 2024-11-30) — Tax Rate For Calcs: 0.21
CXH balance_sheet (annual, 2024-11-30) — Total Assets: 118509002.00
CXH balance_sheet (quarterly, 2024-11-30) — Total Assets: 118509002.00
CXH balance_sheet (annual, 2024-11-30) — Total Equity Gross Minority Interest: 73568010.00
CXH balance_sheet (quarterly, 2024-11-30) — Total Equity Gross Minority Interest: 73568010.00
CXH balance_sheet (annual, 2024-11-30) — Total Liabilities Net Minority Interest: 44940992.00
CXH balance_sheet (quarterly, 2024-11-30) — Total Liabilities Net Minority Interest: 44940992.00
CXH balance_sheet (quarterly, 2025-05-31) — Accounts Payable: 411761.00
CXH balance_sheet (quarterly, 2025-05-31) — Capital Stock: 78355439.00
CXH balance_sheet (quarterly, 2025-05-31) — Common Stock: 78355439.00
CXH balance_sheet (quarterly, 2025-05-31) — Common Stock Equity: 67390385.00
CXH balance_sheet (quarterly, 2025-05-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 109650890.00
CXH balance_sheet (quarterly, 2025-05-31) — Investmentin Financial Assets: 109650890.00
CXH balance_sheet (quarterly, 2025-05-31) — Investments And Advances: 109650890.00
CXH balance_sheet (quarterly, 2025-05-31) — Net Tangible Assets: 67390385.00
CXH balance_sheet (quarterly, 2025-05-31) — Ordinary Shares Number: 8199220.00
CXH balance_sheet (quarterly, 2025-05-31) — Other Payable: 6767633.00
CXH balance_sheet (quarterly, 2025-05-31) — Payables: 7179394.00
CXH balance_sheet (quarterly, 2025-05-31) — Preferred Securities Outside Stock Equity: 37200000.00
CXH balance_sheet (quarterly, 2025-05-31) — Receivables: 2185862.00
CXH balance_sheet (quarterly, 2025-05-31) — Retained Earnings: -10965054.00
CXH balance_sheet (quarterly, 2025-05-31) — Share Issued: 8199220.00
CXH balance_sheet (quarterly, 2025-05-31) — Stockholders Equity: 67390385.00
CXH balance_sheet (quarterly, 2025-05-31) — Tangible Book Value: 67390385.00
CXH balance_sheet (quarterly, 2025-05-31) — Total Assets: 111851338.00
CXH balance_sheet (quarterly, 2025-05-31) — Total Equity Gross Minority Interest: 67390385.00
CXH balance_sheet (quarterly, 2025-05-31) — Total Liabilities Net Minority Interest: 44460953.00
CXH income_statement (annual, 2025-11-30) — +Operating Expense: 74617.00
CXH income_statement (annual, 2025-11-30) — +Total Revenue: 188659.00
CXH balance_sheet (annual, 2025-11-30) — Accounts Payable: 791194.00
CXH balance_sheet (quarterly, 2025-11-30) — Accounts Payable: 791194.00
CXH cash_flow (annual, 2025-11-30) — Beginning Cash Position: 31456.00
CXH balance_sheet (annual, 2025-11-30) — Capital Stock: 78355439.00
CXH balance_sheet (quarterly, 2025-11-30) — Capital Stock: 78355439.00
CXH balance_sheet (annual, 2025-11-30) — Cash And Cash Equivalents: 1370.00
CXH balance_sheet (quarterly, 2025-11-30) — Cash And Cash Equivalents: 1370.00
CXH balance_sheet (annual, 2025-11-30) — Cash Cash Equivalents And Federal Funds Sold: 1370.00
CXH balance_sheet (quarterly, 2025-11-30) — Cash Cash Equivalents And Federal Funds Sold: 1370.00
CXH cash_flow (annual, 2025-11-30) — Cash Dividends Paid: -2999591.00
CXH balance_sheet (annual, 2025-11-30) — Cash Financial: 1370.00
CXH balance_sheet (quarterly, 2025-11-30) — Cash Financial: 1370.00
CXH cash_flow (annual, 2025-11-30) — Change In Accrued Expense: -10710.00
CXH cash_flow (annual, 2025-11-30) — Change In Other Current Assets: -8.00
CXH cash_flow (annual, 2025-11-30) — Change In Other Current Liabilities: 0.00
CXH cash_flow (annual, 2025-11-30) — Change In Payable: -17212.00
CXH cash_flow (annual, 2025-11-30) — Change In Receivables: -18589.00
CXH cash_flow (annual, 2025-11-30) — Change In Working Capital: -46519.00
CXH cash_flow (annual, 2025-11-30) — Changes In Cash: -30086.00
CXH balance_sheet (annual, 2025-11-30) — Common Stock: 78355439.00
CXH balance_sheet (quarterly, 2025-11-30) — Common Stock: 78355439.00
CXH cash_flow (annual, 2025-11-30) — Common Stock Dividend Paid: -2999591.00
CXH balance_sheet (annual, 2025-11-30) — Common Stock Equity: 70681138.00
CXH balance_sheet (quarterly, 2025-11-30) — Common Stock Equity: 70681138.00
CXH income_statement (annual, 2025-11-30) — Diluted NI Availto Com Stockholders: 114042.00
CXH cash_flow (annual, 2025-11-30) — End Cash Position: 1370.00
CXH balance_sheet (annual, 2025-11-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 113110443.00
CXH balance_sheet (quarterly, 2025-11-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 113110443.00
CXH cash_flow (annual, 2025-11-30) — Financing Cash Flow: -3004591.00
CXH cash_flow (annual, 2025-11-30) — Free Cash Flow: 2974505.00
CXH cash_flow (annual, 2025-11-30) — Gain Loss On Investment Securities: 2741317.00
CXH income_statement (annual, 2025-11-30) — Gain On Sale Of Security: -757527.00
CXH income_statement (annual, 2025-11-30) — General And Administrative Expense: 267522.00
CXH income_statement (annual, 2025-11-30) — Interest Expense: 1693665.00
CXH income_statement (annual, 2025-11-30) — Interest Income: 5357450.00
CXH balance_sheet (annual, 2025-11-30) — Investmentin Financial Assets: 113110443.00
CXH balance_sheet (quarterly, 2025-11-30) — Investmentin Financial Assets: 113110443.00
CXH balance_sheet (annual, 2025-11-30) — Investments And Advances: 113110443.00
CXH balance_sheet (quarterly, 2025-11-30) — Investments And Advances: 113110443.00
CXH cash_flow (annual, 2025-11-30) — Issuance Of Debt: 810000.00
CXH cash_flow (annual, 2025-11-30) — Long Term Debt Issuance: 810000.00
CXH cash_flow (annual, 2025-11-30) — Long Term Debt Payments: -815000.00
CXH income_statement (annual, 2025-11-30) — Net Income: 114042.00
CXH income_statement (annual, 2025-11-30) — Net Income Common Stockholders: 114042.00
CXH income_statement (annual, 2025-11-30) — Net Income Continuous Operations: 114042.00
CXH income_statement (annual, 2025-11-30) — Net Income From Continuing And Discontinued Operation: 114042.00
CXH income_statement (annual, 2025-11-30) — Net Income From Continuing Operation Net Minority Interest: 114042.00
CXH cash_flow (annual, 2025-11-30) — Net Income From Continuing Operations: 114042.00
CXH income_statement (annual, 2025-11-30) — Net Income Including Noncontrolling Interests: 114042.00
CXH income_statement (annual, 2025-11-30) — Net Interest Income: 3663785.00
CXH cash_flow (annual, 2025-11-30) — Net Issuance Payments Of Debt: -5000.00
CXH cash_flow (annual, 2025-11-30) — Net Long Term Debt Issuance: -5000.00
CXH cash_flow (annual, 2025-11-30) — Net Other Financing Charges: 0.00
CXH balance_sheet (annual, 2025-11-30) — Net Tangible Assets: 70681138.00
CXH balance_sheet (quarterly, 2025-11-30) — Net Tangible Assets: 70681138.00
CXH income_statement (annual, 2025-11-30) — Normalized Income: 114042.00
CXH cash_flow (annual, 2025-11-30) — Operating Cash Flow: 2974505.00
CXH income_statement (annual, 2025-11-30) — Operating Revenue: 188659.00
CXH balance_sheet (annual, 2025-11-30) — Ordinary Shares Number: 8199220.00
CXH balance_sheet (quarterly, 2025-11-30) — Ordinary Shares Number: 8199220.00
CXH cash_flow (annual, 2025-11-30) — Other Non Cash Items: 165665.00
CXH income_statement (annual, 2025-11-30) — Other Operating Expenses: -192905.00
CXH balance_sheet (annual, 2025-11-30) — Other Payable: 6738786.00
CXH balance_sheet (quarterly, 2025-11-30) — Other Payable: 6738786.00
CXH balance_sheet (annual, 2025-11-30) — Payables: 7529980.00
CXH balance_sheet (quarterly, 2025-11-30) — Payables: 7529980.00
CXH balance_sheet (annual, 2025-11-30) — Preferred Securities Outside Stock Equity: 37200000.00
CXH balance_sheet (quarterly, 2025-11-30) — Preferred Securities Outside Stock Equity: 37200000.00
CXH income_statement (annual, 2025-11-30) — Pretax Income: 114042.00
CXH balance_sheet (annual, 2025-11-30) — Receivables: 2401146.00
CXH balance_sheet (quarterly, 2025-11-30) — Receivables: 2401146.00
CXH cash_flow (annual, 2025-11-30) — Repayment Of Debt: -815000.00
CXH balance_sheet (annual, 2025-11-30) — Retained Earnings: -7674301.00
CXH balance_sheet (quarterly, 2025-11-30) — Retained Earnings: -7674301.00
CXH income_statement (annual, 2025-11-30) — Selling General And Administration: 267522.00
CXH balance_sheet (annual, 2025-11-30) — Share Issued: 8199220.00
CXH balance_sheet (quarterly, 2025-11-30) — Share Issued: 8199220.00
CXH balance_sheet (annual, 2025-11-30) — Stockholders Equity: 70681138.00
CXH balance_sheet (quarterly, 2025-11-30) — Stockholders Equity: 70681138.00
CXH balance_sheet (annual, 2025-11-30) — Tangible Book Value: 70681138.00
CXH balance_sheet (quarterly, 2025-11-30) — Tangible Book Value: 70681138.00
CXH income_statement (annual, 2025-11-30) — Tax Effect Of Unusual Items: 0.00
CXH income_statement (annual, 2025-11-30) — Tax Rate For Calcs: 0.21
CXH balance_sheet (annual, 2025-11-30) — Total Assets: 115514975.00
CXH balance_sheet (quarterly, 2025-11-30) — Total Assets: 115514975.00
CXH balance_sheet (annual, 2025-11-30) — Total Equity Gross Minority Interest: 70681138.00
CXH balance_sheet (quarterly, 2025-11-30) — Total Equity Gross Minority Interest: 70681138.00
CXH balance_sheet (annual, 2025-11-30) — Total Liabilities Net Minority Interest: 44833837.00
CXH balance_sheet (quarterly, 2025-11-30) — Total Liabilities Net Minority Interest: 44833837.00
CXI.TO balance_sheet (annual, 2021-10-31) — Current Debt: 4037468.00
CXI.TO cash_flow (annual, 2021-10-31) — Deferred Income Tax: 986481.00
CXI.TO cash_flow (annual, 2021-10-31) — Deferred Tax: 986481.00
CXI.TO cash_flow (annual, 2021-10-31) — Gain Loss On Investment Securities: -365429.00
CXI.TO balance_sheet (annual, 2021-10-31) — Line Of Credit: 4037468.00
CXI.TO cash_flow (annual, 2021-10-31) — Net Business Purchase And Sale: -373025.00
CXI.TO cash_flow (annual, 2021-10-31) — Net Other Financing Charges: 208203.00
CXI.TO cash_flow (annual, 2021-10-31) — Operating Gains Losses: 104191.00
CXI.TO balance_sheet (annual, 2021-10-31) — Other Properties: 3351.00
CXI.TO balance_sheet (annual, 2021-10-31) — Other Receivables: 3502067.00
CXI.TO income_statement (annual, 2021-10-31) — Other Special Charges: 18989.00
CXI.TO income_statement (annual, 2021-10-31) — Provision For Doubtful Accounts: 112299.00
CXI.TO cash_flow (annual, 2021-10-31) — Purchase Of Business: -373025.00
CXI.TO balance_sheet (annual, 2021-10-31) — Restricted Cash: 1696600.00
CXI.TO income_statement (annual, 2021-10-31) — Restructuring And Mergern Acquisition: 73027.00
CXI.TO balance_sheet (annual, 2021-10-31) — Taxes Receivable: 869136.00
CXI.TO income_statement (annual, 2021-10-31) — Write Off: 23684.00
CXI.TO income_statement (annual, 2022-10-31) — +Operating Expense: 22034543.00
CXI.TO income_statement (annual, 2022-10-31) — +Total Revenue: 67498673.00
CXI.TO balance_sheet (annual, 2022-10-31) — Accounts Payable: 27839239.00
CXI.TO balance_sheet (annual, 2022-10-31) — Accounts Receivable: 14273528.00
CXI.TO balance_sheet (annual, 2022-10-31) — Accumulated Depreciation: -4212303.00
CXI.TO balance_sheet (annual, 2022-10-31) — Additional Paid In Capital: 32698075.00
CXI.TO income_statement (annual, 2022-10-31) — Basic Average Shares: 6429489.00
CXI.TO income_statement (annual, 2022-10-31) — Basic EPS: 1.83
CXI.TO cash_flow (annual, 2022-10-31) — Beginning Cash Position: 66527690.00
CXI.TO balance_sheet (annual, 2022-10-31) — Buildings And Improvements: 4093843.00
CXI.TO cash_flow (annual, 2022-10-31) — Capital Expenditure: -917992.00
CXI.TO balance_sheet (annual, 2022-10-31) — Capital Lease Obligations: 4531059.00
CXI.TO balance_sheet (annual, 2022-10-31) — Capital Stock: 6429489.00
CXI.TO balance_sheet (annual, 2022-10-31) — Cash And Cash Equivalents: 88559268.00
CXI.TO balance_sheet (annual, 2022-10-31) — Cash Cash Equivalents And Short Term Investments: 88559268.00
CXI.TO balance_sheet (annual, 2022-10-31) — Cash Financial: 88559268.00
CXI.TO cash_flow (annual, 2022-10-31) — Cash Flow From Continuing Financing Activities: 214147.00
CXI.TO cash_flow (annual, 2022-10-31) — Cash Flow From Continuing Investing Activities: -1291015.00
CXI.TO cash_flow (annual, 2022-10-31) — Cash Flow From Continuing Operating Activities: 25518520.00
CXI.TO cash_flow (annual, 2022-10-31) — Change In Account Payable: 11295242.00
CXI.TO cash_flow (annual, 2022-10-31) — Change In Other Current Assets: -785205.00
CXI.TO cash_flow (annual, 2022-10-31) — Change In Other Working Capital: -3658546.00
CXI.TO cash_flow (annual, 2022-10-31) — Change In Payable: 11295242.00
CXI.TO cash_flow (annual, 2022-10-31) — Change In Payables And Accrued Expense: 11295242.00
CXI.TO cash_flow (annual, 2022-10-31) — Change In Receivables: 2473487.00
CXI.TO cash_flow (annual, 2022-10-31) — Change In Working Capital: 9324978.00
CXI.TO cash_flow (annual, 2022-10-31) — Changes In Account Receivables: 1541946.00
CXI.TO cash_flow (annual, 2022-10-31) — Changes In Cash: 24441652.00
CXI.TO balance_sheet (annual, 2022-10-31) — Common Stock: 6429489.00
CXI.TO balance_sheet (annual, 2022-10-31) — Common Stock Equity: 69305509.00
CXI.TO income_statement (annual, 2022-10-31) — Cost Of Revenue: 26371728.00
CXI.TO balance_sheet (annual, 2022-10-31) — Current Accrued Expenses: 4933897.00
CXI.TO balance_sheet (annual, 2022-10-31) — Current Assets: 112438659.00
CXI.TO balance_sheet (annual, 2022-10-31) — Current Capital Lease Obligation: 1545777.00
CXI.TO balance_sheet (annual, 2022-10-31) — Current Debt: 5929847.00
CXI.TO balance_sheet (annual, 2022-10-31) — Current Debt And Capital Lease Obligation: 7475624.00
CXI.TO balance_sheet (annual, 2022-10-31) — Current Deferred Liabilities: 507887.00
CXI.TO balance_sheet (annual, 2022-10-31) — Current Deferred Revenue: 507887.00
CXI.TO balance_sheet (annual, 2022-10-31) — Current Liabilities: 52059780.00
CXI.TO cash_flow (annual, 2022-10-31) — Depreciation: 3272956.00
CXI.TO cash_flow (annual, 2022-10-31) — Depreciation Amortization Depletion: 3272956.00
CXI.TO income_statement (annual, 2022-10-31) — Depreciation Amortization Depletion Income Statement: 3272956.00
CXI.TO cash_flow (annual, 2022-10-31) — Depreciation And Amortization: 3272956.00
CXI.TO income_statement (annual, 2022-10-31) — Depreciation And Amortization In Income Statement: 3272956.00
CXI.TO income_statement (annual, 2022-10-31) — Depreciation Income Statement: 3272956.00
CXI.TO income_statement (annual, 2022-10-31) — Diluted Average Shares: 6635412.00
CXI.TO income_statement (annual, 2022-10-31) — Diluted EPS: 1.78
CXI.TO income_statement (annual, 2022-10-31) — Diluted NI Availto Com Stockholders: 11783124.00
CXI.TO income_statement (annual, 2022-10-31) — EBIT: 15558387.00
CXI.TO income_statement (annual, 2022-10-31) — EBITDA: 18831343.00
CXI.TO cash_flow (annual, 2022-10-31) — Effect Of Exchange Rate Changes: -2410074.00
CXI.TO cash_flow (annual, 2022-10-31) — End Cash Position: 88559268.00
CXI.TO cash_flow (annual, 2022-10-31) — Financing Cash Flow: 214147.00
CXI.TO cash_flow (annual, 2022-10-31) — Free Cash Flow: 24600528.00
CXI.TO income_statement (annual, 2022-10-31) — Gain On Sale Of Ppe: 0.00
CXI.TO income_statement (annual, 2022-10-31) — Gain On Sale Of Security: -1472299.00
CXI.TO balance_sheet (annual, 2022-10-31) — Gains Losses Not Affecting Retained Earnings: -6244766.00
CXI.TO income_statement (annual, 2022-10-31) — General And Administrative Expense: 15274448.00
CXI.TO balance_sheet (annual, 2022-10-31) — Goodwill: 2187445.00
CXI.TO balance_sheet (annual, 2022-10-31) — Goodwill And Other Intangible Assets: 6470071.00
CXI.TO balance_sheet (annual, 2022-10-31) — Gross PPE: 9019259.00
CXI.TO income_statement (annual, 2022-10-31) — Gross Profit: 41126945.00
CXI.TO balance_sheet (annual, 2022-10-31) — Hedging Assets Current: 911443.00
CXI.TO cash_flow (annual, 2022-10-31) — Income Tax Paid Supplemental Data: 1218406.00
CXI.TO balance_sheet (annual, 2022-10-31) — Income Tax Payable: 2166087.00
CXI.TO income_statement (annual, 2022-10-31) — Insurance And Claims: 1012225.00
CXI.TO income_statement (annual, 2022-10-31) — Interest Expense: 1345830.00
CXI.TO income_statement (annual, 2022-10-31) — Interest Expense Non Operating: 1345830.00
CXI.TO income_statement (annual, 2022-10-31) — Interest Income: 111684.00
CXI.TO income_statement (annual, 2022-10-31) — Interest Income Non Operating: 111684.00
CXI.TO cash_flow (annual, 2022-10-31) — Interest Paid Supplemental Data: 1345830.00
CXI.TO balance_sheet (annual, 2022-10-31) — Invested Capital: 75235356.00
CXI.TO cash_flow (annual, 2022-10-31) — Investing Cash Flow: -1291015.00
CXI.TO balance_sheet (annual, 2022-10-31) — Leases: 3122707.00
CXI.TO balance_sheet (annual, 2022-10-31) — Line Of Credit: 5929847.00
CXI.TO balance_sheet (annual, 2022-10-31) — Long Term Capital Lease Obligation: 2985282.00
CXI.TO balance_sheet (annual, 2022-10-31) — Long Term Debt And Capital Lease Obligation: 2985282.00
CXI.TO cash_flow (annual, 2022-10-31) — Long Term Debt Payments: -2077990.00
CXI.TO balance_sheet (annual, 2022-10-31) — Machinery Furniture Equipment: 1801043.00
CXI.TO cash_flow (annual, 2022-10-31) — Net Business Purchase And Sale: -373023.00
CXI.TO income_statement (annual, 2022-10-31) — Net Income: 11783124.00
CXI.TO income_statement (annual, 2022-10-31) — Net Income Common Stockholders: 11783124.00
CXI.TO income_statement (annual, 2022-10-31) — Net Income Continuous Operations: 11783124.00
CXI.TO income_statement (annual, 2022-10-31) — Net Income From Continuing And Discontinued Operation: 11783124.00
CXI.TO income_statement (annual, 2022-10-31) — Net Income From Continuing Operation Net Minority Interest: 11783124.00
CXI.TO cash_flow (annual, 2022-10-31) — Net Income From Continuing Operations: 11783124.00
CXI.TO income_statement (annual, 2022-10-31) — Net Income Including Noncontrolling Interests: 11783124.00
CXI.TO cash_flow (annual, 2022-10-31) — Net Intangibles Purchase And Sale: -354373.00
CXI.TO income_statement (annual, 2022-10-31) — Net Interest Income: -3405732.00
CXI.TO cash_flow (annual, 2022-10-31) — Net Issuance Payments Of Debt: -33035.00
CXI.TO cash_flow (annual, 2022-10-31) — Net Long Term Debt Issuance: -2077990.00
CXI.TO income_statement (annual, 2022-10-31) — Net Non Operating Interest Income Expense: -3405732.00
CXI.TO cash_flow (annual, 2022-10-31) — Net Other Financing Charges: 166183.00
CXI.TO balance_sheet (annual, 2022-10-31) — Net PPE: 4806956.00
CXI.TO cash_flow (annual, 2022-10-31) — Net PPE Purchase And Sale: -563619.00
CXI.TO cash_flow (annual, 2022-10-31) — Net Short Term Debt Issuance: 2044955.00
CXI.TO balance_sheet (annual, 2022-10-31) — Net Tangible Assets: 62835438.00
CXI.TO balance_sheet (annual, 2022-10-31) — Non Current Deferred Assets: 1692004.00
CXI.TO balance_sheet (annual, 2022-10-31) — Non Current Deferred Taxes Assets: 1692004.00
CXI.TO income_statement (annual, 2022-10-31) — Normalized EBITDA: 20303642.00
CXI.TO income_statement (annual, 2022-10-31) — Normalized Income: 13003754.58
CXI.TO cash_flow (annual, 2022-10-31) — Operating Cash Flow: 25518520.00
CXI.TO cash_flow (annual, 2022-10-31) — Operating Gains Losses: 11180.00
CXI.TO income_statement (annual, 2022-10-31) — Operating Income: 19092402.00
CXI.TO income_statement (annual, 2022-10-31) — Operating Revenue: 67498673.00
CXI.TO balance_sheet (annual, 2022-10-31) — Ordinary Shares Number: 6429489.00
CXI.TO balance_sheet (annual, 2022-10-31) — Other Current Assets: 3782040.00
CXI.TO balance_sheet (annual, 2022-10-31) — Other Current Liabilities: 9137046.00
CXI.TO balance_sheet (annual, 2022-10-31) — Other Equity Adjustments: -6244766.00
CXI.TO balance_sheet (annual, 2022-10-31) — Other Equity Interest: 3907257.00
CXI.TO income_statement (annual, 2022-10-31) — Other Gand A: 12036086.00
CXI.TO income_statement (annual, 2022-10-31) — Other Income Expense: -1474113.00
CXI.TO balance_sheet (annual, 2022-10-31) — Other Intangible Assets: 4282626.00
CXI.TO cash_flow (annual, 2022-10-31) — Other Non Cash Items: 32635.00
CXI.TO balance_sheet (annual, 2022-10-31) — Other Non Current Assets: 121142.00
CXI.TO balance_sheet (annual, 2022-10-31) — Other Non Current Liabilities: 1178261.00
CXI.TO income_statement (annual, 2022-10-31) — Other Non Operating Income Expenses: -1814.00
CXI.TO income_statement (annual, 2022-10-31) — Other Operating Expenses: 3487139.00
CXI.TO balance_sheet (annual, 2022-10-31) — Other Properties: 1666.00
CXI.TO balance_sheet (annual, 2022-10-31) — Other Receivables: 3249262.00
CXI.TO income_statement (annual, 2022-10-31) — Other Special Charges: 37985.00
CXI.TO balance_sheet (annual, 2022-10-31) — Payables: 30005326.00
CXI.TO balance_sheet (annual, 2022-10-31) — Payables And Accrued Expenses: 34939223.00
CXI.TO balance_sheet (annual, 2022-10-31) — Prepaid Assets: 1109251.00
CXI.TO income_statement (annual, 2022-10-31) — Pretax Income: 14212557.00
CXI.TO cash_flow (annual, 2022-10-31) — Proceeds From Stock Option Exercised: 80999.00
CXI.TO balance_sheet (annual, 2022-10-31) — Properties: 0.00
CXI.TO income_statement (annual, 2022-10-31) — Provision For Doubtful Accounts: 0.00
CXI.TO cash_flow (annual, 2022-10-31) — Purchase Of Business: -373023.00
CXI.TO cash_flow (annual, 2022-10-31) — Purchase Of Intangibles: -354373.00
CXI.TO cash_flow (annual, 2022-10-31) — Purchase Of PPE: -563619.00
CXI.TO balance_sheet (annual, 2022-10-31) — Receivables: 14273528.00
CXI.TO income_statement (annual, 2022-10-31) — Reconciled Cost Of Revenue: 26371728.00
CXI.TO income_statement (annual, 2022-10-31) — Reconciled Depreciation: 3272956.00
CXI.TO income_statement (annual, 2022-10-31) — Rent And Landing Fees: 1132490.00
CXI.TO income_statement (annual, 2022-10-31) — Rent Expense Supplemental: 1132490.00
CXI.TO cash_flow (annual, 2022-10-31) — Repayment Of Debt: -2077990.00
CXI.TO balance_sheet (annual, 2022-10-31) — Restricted Cash: 3803129.00
CXI.TO balance_sheet (annual, 2022-10-31) — Retained Earnings: 32515454.00
CXI.TO income_statement (annual, 2022-10-31) — Salaries And Wages: 1093647.00
CXI.TO income_statement (annual, 2022-10-31) — Selling General And Administration: 15274448.00
CXI.TO balance_sheet (annual, 2022-10-31) — Share Issued: 6429489.00
CXI.TO income_statement (annual, 2022-10-31) — Special Income Charges: 0.00
CXI.TO cash_flow (annual, 2022-10-31) — Stock Based Compensation: 1093647.00
CXI.TO balance_sheet (annual, 2022-10-31) — Stockholders Equity: 69305509.00
CXI.TO balance_sheet (annual, 2022-10-31) — Tangible Book Value: 62835438.00
CXI.TO income_statement (annual, 2022-10-31) — Tax Effect Of Unusual Items: -251668.42